Handel nachbörslich: 2.06 0.06 +3.00%

Neuraxis Inc (NRXS)

Überblick Nachrichten Preisverlauf Forum Prognose

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Neuraxis Inc (NRXS)

Neuraxis Inc Aktie (NRXS) Neueste Nachrichten

Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025 - The Manila Times

The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis - Yahoo Finance

Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems - Yahoo Finance

Small Cap Med-Tech Names Are More Insulated from Tariff Fallout - The Wall Street Transcript

Interview with the President and CEO: BioVie Inc. (NASDAQ:BIVI) - The Wall Street Transcript

Interview with the CEO: Abivax SA (NASDAQ:ABVX) - The Wall Street Transcript

Onshoring Drug Manufacturing Is Critical, But Not Easy - The Wall Street Transcript

Enphase Energy, Inc. (NASDAQ:ENPH) Given Average Rating of “Hold” by Analysts - Defense World

NeurAxis, Inc. (NASDAQ:NRXS) Stake Reduced by Bank of Montreal Can - Defense World

NeurAxis (NASDAQ:NRXS) Stock Price Up 10.3% – Still a Buy? - Defense World

NRXS stock touches 52-week low at $1.38 amid market challenges By Investing.com - Investing.com South Africa

NRXS stock touches 52-week low at $1.38 amid market challenges - Investing.com India

NeurAxis to Present at the Planet MicroCap Showcase: VEGAS - GlobeNewswire

NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on - Bluefield Daily Telegraph

NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 - Yahoo Finance

Vagus Nerve Stimulators Market Deep Research Report with - openPR.com

Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World

Neuraxis stock hits 52-week low at $1.98 amid market challenges By Investing.com - Investing.com South Africa

Neuraxis stock hits 52-week low at $1.98 amid market challenges - Investing.com India

NeurAxis, Inc. (NASDAQ:NRXS) Q4 2024 Earnings Call Transcript - MSN

NeurAxis (NASDAQ:NRXS) Trading Down 0.9% – Should You Sell? - Defense World

NeurAxis Stock Gains Post Q4 Earnings And Revenue Growth - Barchart

NeurAxis Stock Gains Post Q4 Earnings and Revenue Growth - Zacks Investment Research

NeurAxis (NASDAQ:NRXS) & BioLife Solutions (NASDAQ:BLFS) Head-To-Head Analysis - Defense World

NeurAxis, Inc. Reports Strong Q4 Growth Amid Challenges - TipRanks

NeurAxis revenues increase 43% to USD 761K in Q4 2024 - Medical Buyer

NeurAxis, Inc. Reports Strong Q4 2024 Results - TipRanks

Earnings call transcript: Neuraxis Q4 2024 sees revenue growth, loss narrows - Investing.com Canada

Earnings call transcript: Neuraxis Q4 2024 sees revenue growth, loss narrows By Investing.com - Investing.com South Africa

NeurAxis Better on Q4 Results - Baystreet.ca

NeurAxis, Inc. Reports 43% Revenue Growth in Q4 2024 and Significant Milestones Achieved - Nasdaq

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues - GlobeNewswire

Earnings Scheduled For March 20, 2025 - Benzinga

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025 - The Manila Times

NeurAxis, Inc. Set to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 20, 2025 - Nasdaq

NRXS stock touches 52-week low at $1.99 amid market challenges By Investing.com - Investing.com South Africa

NRXS stock touches 52-week low at $1.99 amid market challenges - Investing.com

Vagus Nerve Stimulators Market Detailed In New Research Report - openPR

NeurAxis (NASDAQ:NRXS) Stock Price Down 2.8% – Here’s Why - Defense World

Chronic Idiopathic Constipation Clinical Trials and Pipeline - openPR

Interview with the Chairman and CEO: The Real Brokerage Inc. (NASDAQ:REAX) - The Wall Street Transcript

Critical Contrast: NeurAxis (NASDAQ:NRXS) & Zynex (NASDAQ:ZYXI) - Defense World

Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR

Ähnlich wie NRXS